Excision BioTherapeutics Appoints Veteran Genome Editing Expert TJ Cradick, PhD as Chief Scientific Officer
August 04, 2020 12:00 ET
|
Excision BioTherapeutics
San Francisco, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, a biotechnology company dedicated to curing viral infectious disease using CRISPR, today announced the appointment of TJ...